# Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

> **NCT00936065** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Moderate to Severe Psoriasis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Etanercept + Acitretin
- **DRUG:** Acitretin

## Key facts

- **NCT ID:** NCT00936065
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936065, "Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00936065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*